JPH0534021B2 - - Google Patents

Info

Publication number
JPH0534021B2
JPH0534021B2 JP2146216A JP14621690A JPH0534021B2 JP H0534021 B2 JPH0534021 B2 JP H0534021B2 JP 2146216 A JP2146216 A JP 2146216A JP 14621690 A JP14621690 A JP 14621690A JP H0534021 B2 JPH0534021 B2 JP H0534021B2
Authority
JP
Japan
Prior art keywords
bone
filling
filler
particles
filling material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2146216A
Other languages
Japanese (ja)
Other versions
JPH0440961A (en
Inventor
Toshuki Kurosawa
Toyohiko Yamamoto
Hiroyasu Takeuchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Materials Corp
Original Assignee
Mitsubishi Materials Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Materials Corp filed Critical Mitsubishi Materials Corp
Priority to JP2146216A priority Critical patent/JPH0440961A/en
Publication of JPH0440961A publication Critical patent/JPH0440961A/en
Publication of JPH0534021B2 publication Critical patent/JPH0534021B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Materials For Medical Uses (AREA)

Description

【発明の詳細な説明】 <産業上の利用分野> 本発明は、生体用セラミツクス材料であつて、
骨欠損部、骨空〓部及び骨吸収部の充填箇所に固
定され、かつ該充填箇所に早期に新生骨の形成を
促進し、生体の骨組織と一体化し得る骨欠損部及
び骨空〓部ならびに骨吸収部充填材に関する。
[Detailed Description of the Invention] <Industrial Application Field> The present invention is a biomedical ceramic material,
Bone defects and bone voids that are fixed at filling points in bone defects, bone voids, and bone resorption areas, and that can promote the early formation of new bone at the filling points and integrate with the bone tissue of the living body. and bone resorption part filling materials.

<従来の技術> 従来歯科治療又は整形外科治療において、歯周
病、抜歯後における歯槽骨の吸収、交通事故若し
くは骨腫瘍等の疾患により失なわれた骨を修復す
るために患者自身の他部位の骨移植等が試みられ
ているが、前記修復法では、損傷箇所以外の骨組
織を切除するため、患者の肉体的及び心理的負担
が極めて大きく、また広範囲な骨欠損部を充填す
る為に十分な量の自家骨を採取できないという問
題がある。
<Conventional technology> In conventional dental treatment or orthopedic treatment, patients' other parts of themselves are used to repair bone lost due to diseases such as periodontal disease, alveolar bone resorption after tooth extraction, traffic accidents, or bone tumors. Attempts have been made to perform bone grafting, etc., but these repair methods place an extremely heavy physical and psychological burden on the patient as bone tissue other than the damaged area is excised, and it is difficult to fill in a wide range of bone defects. There is a problem that a sufficient amount of autologous bone cannot be collected.

そこで、前述の問題を解決するために、生体の
硬組織代替物質として、各種金属合金及び有機物
質等が提案されている。しかしながら前記各種金
属合金及び有機物質等は、一般に生体環境下にお
いて使用する場合、溶解劣下や生体に対する毒性
等の異物反応を伴なうという問題がある。
In order to solve the above-mentioned problems, various metal alloys, organic substances, and the like have been proposed as hard tissue substitutes for living bodies. However, when the various metal alloys and organic substances mentioned above are generally used in a biological environment, there is a problem in that they are accompanied by foreign body reactions such as poor solubility and toxicity to living organisms.

また最近では、生体との親和性に優れ、かつ前
記欠点のないアルミナ、リン酸三カルシウム又は
ヒドロキシアパタイトの焼結体若しくは単結晶か
ら成る充填材等のセラミツク系材料が注目されて
いる。中でもヒドロキシアパタイトは、充填後早
期に骨の新生が期待でき、更にアルミナのように
結合組織を介することなく新生骨と接する等の利
点を有しているので、特に生体親和性に優れた材
料として知られている。該ヒドロキシアパタイト
を使用した充填材は、構造上の特徴から、表面と
内部とを結ぶ連通気孔を有する多孔質充填材と、
内部に殆んど気孔を持たない緻密質充填材とに大
別される。前記多孔質充填材は、顆粒状であつて
も、充填後容易に移動することなく充填箇所に固
定され、また早期骨形成能に優れているものの、
充填後若しくは縫合後充填箇所に荷重を加える
と、多孔質充填材が破壊され、充填箇所が沈下す
るなど強度的に弱いという欠点がある。
Recently, ceramic materials such as fillers made of sintered bodies or single crystals of alumina, tricalcium phosphate, or hydroxyapatite, which have excellent compatibility with living organisms and do not have the above-mentioned drawbacks, have attracted attention. Among them, hydroxyapatite can be expected to generate new bone quickly after filling, and unlike alumina, it has the advantage of coming into contact with new bone without going through connective tissue, so it has been used as a material with particularly excellent biocompatibility. Are known. Due to its structural characteristics, the filler using hydroxyapatite is a porous filler having continuous pores connecting the surface and the inside;
It is broadly classified into dense filling material with almost no pores inside. Even though the porous filling material is in the form of granules, it is fixed at the filling site without easily moving after filling, and has excellent early bone formation ability;
If a load is applied to the filling area after filling or suturing, the porous filling material is destroyed and the filling area sinks, resulting in weak strength.

また緻密質充填材は、強度においては優れるも
のの、顆粒状である場合、圧密充填をしないと充
填箇所より移動するという欠点が生じ、したがつ
て優れた生体親和性を有するにもかかわらず、骨
形成が遅延するという問題が生じる。
In addition, although dense filling materials have excellent strength, they have the disadvantage that if they are in granular form, they will move from the filling site unless compacted. The problem arises that the formation is delayed.

更にまた、充填箇所に固定して充填し得る充填
材として、最短径0.1〜3.0mmであつて、かつ比表
面積形状係数φが6.3〜15の緻密質充填材(特開
昭61−20558号公報)が提案されている。しかし
該充填材においても、充填箇所への固定が未だ十
分でないのが現状である。
Furthermore, as a filler that can be fixed and filled at a filling location, a dense filler having a shortest diameter of 0.1 to 3.0 mm and a specific surface area shape factor φ of 6.3 to 15 (Japanese Patent Application Laid-Open No. 61-20558 ) has been proposed. However, even with this filling material, the current situation is that it is still not sufficiently fixed to the filling location.

<発明が解決しようとする課題> したがつて本発明の目的は、生体親和性及び早
期骨形成能に優れ、必らずしも圧密充填等をしな
くても充填箇所に確実に固定され、かつ実用上の
強度も十分であり、しかも手術をする際に弊害の
ない理想的な骨欠損部及び骨空〓部ならびに骨吸
収部充填材を提供することにある。
<Problems to be Solved by the Invention> Therefore, an object of the present invention is to provide a material that has excellent biocompatibility and early bone formation ability, and that can be reliably fixed at the filling site without necessarily performing compaction filling, etc. The object of the present invention is to provide an ideal filling material for bone defects, bone cavities, and bone resorption sites that has sufficient strength for practical use and does not cause any adverse effects during surgery.

<課題を解決するための手段> 本発明によれば、ヒドロキシアパタイトから成
る粒子であつて、該粒子の最短径が0.1〜3.0mmで
あり、かつ表面に孔径が数μm〜500μmの複数
の窪みを具備したことを特徴とする骨欠損部及び
骨空〓部ならびに骨吸収部充填材が提供される。
<Means for Solving the Problems> According to the present invention, the particles are made of hydroxyapatite, the shortest diameter of the particles is 0.1 to 3.0 mm, and the surface has a plurality of depressions with pore diameters of several μm to 500 μm. A filling material for a bone defect, a bone cavity, and a bone resorption region is provided, which is characterized by comprising the following.

以下本発明を更に詳細に説明する。 The present invention will be explained in more detail below.

本発明の骨欠損部及び骨空〓部ならびに骨吸収
部充填材は、骨形成促進能力に優れたヒドロキシ
アパタイトから成る粒子であつて、該粒子の表面
に、充填材を充填箇所に固定し、また新生骨細胞
の付着・増殖を良好にする目的で、該粒子の表面
に特定の最短径を有する複数の窪みを具備するこ
とを特徴とする。
The filling material for bone defects, bone cavities, and bone resorption areas of the present invention is particles made of hydroxyapatite that has an excellent ability to promote bone formation, and the filling material is fixed to the filling site on the surface of the particles, In addition, the particle is characterized in that the surface thereof is provided with a plurality of depressions having a specific shortest diameter in order to improve the adhesion and proliferation of new bone cells.

本発明の骨欠損部及び骨空〓部ならびに骨吸収
部充填材、即ちヒドロキシアパタイトから成る粒
子の最短径は、0.1〜3.0mmの範囲である。前記粒
子の最短径が0.1mm未満の場合には骨欠損部及び
骨空〓部ならびに骨吸収部に充填した際、粒子同
志が接して生じる間〓が、体液成分を侵入させる
のに不適当な大きさとなり、また粒子が細かいた
めに、充填後血液等の体液によつて縫合部より該
粒子が体外に押し出されたり、体内の他部位へ移
動しやすくなり、充填を必要とする部位への固定
が困難となる。一方最短径が3.0mmを超える場合
には、骨欠損部及び骨空〓部ならびに骨吸収部へ
の充填量が少なくなり、また粒子間の間〓が大き
すぎるために、間〓内を骨組織で埋め尽くすまで
の長時間を要し、更には、歯科分野における使用
において、抜歯窩などへ充填する場合、粘膜表面
に顕著な凹凸が生じ外観上及び機能上問題がある
ので前記範囲内とする必要がある。
The shortest diameter of the filler for bone defects, bone cavities, and bone resorption sites of the present invention, that is, particles made of hydroxyapatite, is in the range of 0.1 to 3.0 mm. If the shortest diameter of the particles is less than 0.1 mm, when filling bone defects, bone cavities, and bone resorption areas, the gaps created when the particles come into contact with each other may be inappropriate for the infiltration of body fluid components. Due to the large size and fineness of the particles, after filling, the particles may be pushed out of the body through the sutures by body fluids such as blood, or may easily move to other parts of the body, leading to the possibility that they may not reach the area that requires filling. Fixation becomes difficult. On the other hand, if the shortest diameter exceeds 3.0 mm, the amount of filling in bone defects, bone voids, and bone resorption areas will be small, and the gaps between the particles will be too large, causing the bone tissue to fill in the gaps. Furthermore, in the dental field, when filling tooth extraction sockets etc., significant unevenness occurs on the mucosal surface, causing problems in terms of appearance and function, so it is set within the above range. There is a need.

本発明において、充填材である粒子の表面に形
成される窪みは、充填材を骨欠損部及び骨空〓部
ならびに骨吸収部へ充填した際に、隣接する充填
材同志を係止させるように固定し、全体として、
充填材を所望の充填箇所に強固に固定させ、更に
は、窪みにより形成される凹凸部が、新生骨細胞
の付着、増殖を良好にするためのものであつて、
該窪みの孔径は、数μm〜500μmの範囲とする
必要があり、更に充填材としての強度を高くする
為には、孔径を数μm〜100μmの範囲とするの
が好ましい。前記孔径が数μmに満たない場合に
は、隣接する充填材同志が係止せず、充填材が所
望の充填箇所より他部位へ移動しやすくなり、ま
た500μmを超えると、強度が低下するため前記
範囲内とする必要がある。また前記窪みの深さは
数μm〜50μmの範囲であるのが好ましい。前記
窪みの深さが数μm未満の場合には、隣接する充
填材において、窪みにより形成される凹凸の係わ
り合いが十分でなく、更には早期における新生骨
細胞の付着が期待できず、50μmを超えると、強
度が低下するので好ましくない。
In the present invention, the depressions formed on the surface of the filler particles are designed to lock adjacent fillers together when the filler is filled into bone defects, bone voids, and bone resorption areas. fixed, as a whole;
The filling material is firmly fixed to the desired filling location, and the uneven portion formed by the depression is for improving the attachment and proliferation of new bone cells,
The pore diameter of the depression needs to be in the range of several μm to 500 μm, and in order to further increase the strength as a filler, the pore diameter is preferably in the range of several μm to 100 μm. If the pore diameter is less than several μm, adjacent fillers will not lock together and the filler will easily move from the desired filling location to another location, and if it exceeds 500 μm, the strength will decrease. Must be within the range. Further, the depth of the depression is preferably in the range of several μm to 50 μm. If the depth of the depression is less than several μm, the unevenness formed by the depression will not have sufficient interaction with the adjacent filling material, and furthermore, the attachment of new bone cells at an early stage cannot be expected. Exceeding this is not preferable because the strength decreases.

更に前記粒子表面に形成される窪みは、充填材
表面全体に対して、10〜100%具備されるのが好
ましく、また前記粒子の比表面積形状係数φは
6.3〜15の範囲であるのが好ましい。前記比表面
積形状係数φが15を超えると粒子の形状が針状と
なり、充填後外力等により粒子が容易に破断粉化
する恐れがあり、更には粉化した細片が生体内の
他部位へ流出する等、生体に好ましくない影響を
及ぼすので好ましくない。一方6.3未満の場合に
は充填後、充填材が充填箇所より他部位へ移動し
やすくなり、充填材表面への骨組織の付着生成が
遅延するので好ましくない。
Furthermore, it is preferable that the depressions formed on the surface of the particles be 10 to 100% of the entire surface of the filler, and the specific surface area shape coefficient φ of the particles is
A range of 6.3 to 15 is preferred. If the specific surface area shape factor φ exceeds 15, the shape of the particles becomes acicular, and the particles may easily break and become powdered due to external force after filling, and furthermore, the powdered pieces may be transferred to other parts of the body. This is not desirable because it may cause unfavorable effects on living organisms, such as leakage. On the other hand, if it is less than 6.3, the filling material tends to move from the filling site to other parts after filling, and the formation of adhesion of bone tissue to the surface of the filling material is delayed, which is not preferable.

本発明の骨欠損部及び骨空〓部ならびの骨吸収
部充填材を調製するには、例えば、粒径0.1〜90μ
mのヒドロキシアパタイト微細粉末を60〜70重量
%スラリーとし、得られたスラリーを、よく撹拌
しスラリー中に多くの気泡を巻き込ませた後、直
ちに乾燥する。なおこの際、スラリーがより気泡
を巻き込みやすくする目的で、スラリー100重量
部に対して、好ましくは1〜10重量部の可燃性有
機物質を加えてもよい。得られた乾燥物を公知の
方法により0.1〜3.0mmの顆粒とした後焼成し、ポ
ツトミル等により得られた粒子表面の突出部に存
在するエツジを取り除く処理を行なうことによつ
て表面に所望の窪みを有し、かつ内部が含浸法で
得られる多孔質顆粒よりも高度に緻密に構成され
た粒子を得ることができる。即ち気泡を多く含む
スラリー乾燥物を粉砕することにより、強度の弱
い気泡部分から割れ、従つて表面部分に所望の窪
みを形成することができる。前記可燃性有機物質
としては焼成後窪みを形成するものであれば良
く、好ましくはポリビニルアルコール、ナフタリ
ンスルホン酸アンモニウム又はポリカルボン酸ア
ンモニウム塩等を挙げることができる。また焼成
温度は700〜1200℃が好ましく、充填材としての
強度を更に高めるために、1000〜1200℃で焼成す
るのが特に好ましい。更に前記充填材の表面は、
窪みにより形成される凹凸部に存在するエツジを
完全に除去するか又は少なくすることが好まし
い。該エツジが大量に存在すると充填箇所周辺の
生体組織に好ましくない影響を与える恐れがあ
り、また充填時に注射筒等を利用して充填する場
合、該注射筒の押し出し口がつまり、充填操作の
妨げとなるので好ましくない。
In order to prepare the filling material for bone defects, bone cavities, and bone resorption areas of the present invention, for example, the particle size is 0.1 to 90μ.
The fine hydroxyapatite powder of m is made into a slurry of 60 to 70% by weight, and the resulting slurry is thoroughly stirred to entrain many air bubbles in the slurry, and then immediately dried. At this time, preferably 1 to 10 parts by weight of a combustible organic substance may be added to 100 parts by weight of the slurry in order to make the slurry more likely to incorporate air bubbles. The obtained dried product is made into granules of 0.1 to 3.0 mm by a known method, and then calcined and processed to remove the edges present in the protruding parts of the obtained particle surface using a pot mill or the like to form the desired surface. It is possible to obtain particles that have depressions and whose interior is more densely structured than porous granules obtained by the impregnation method. That is, by pulverizing a dried slurry containing many bubbles, the bubbles can be broken starting from the weaker-strength portions, thereby forming desired depressions in the surface portion. The combustible organic substance may be any substance that forms a depression after firing, and preferable examples include polyvinyl alcohol, ammonium naphthalene sulfonate, ammonium polycarboxylate salt, and the like. Further, the firing temperature is preferably 700 to 1200°C, and particularly preferably 1000 to 1200°C in order to further increase the strength as a filler. Furthermore, the surface of the filler is
It is preferable to completely remove or reduce the edges present in the uneven portion formed by the depression. If these edges are present in large quantities, they may have an unfavorable effect on the living tissue around the filling point, and if a syringe is used for filling, the ejection opening of the syringe may become clogged, interfering with the filling operation. This is not desirable.

<発明の効果> 本発明の骨欠損部及び骨空〓部ならびに骨吸収
部充填材は、表面に数μm〜500μmの窪みを複
数具備しているため、所望の充填箇所に確実に固
定することができ、しかも早期における新生骨細
胞の付着・増殖を促進することができる。更に前
記表面構造に加え、充填材の内部構造が緻密質で
あるため、強度的にも充分であり、したがつて外
力による作用を受け易すい歯周外科、整形外科等
における骨欠損部及び骨空〓部ならびに骨吸収部
充填材として極めて有用である。
<Effects of the Invention> The filling material for bone defects, bone cavities, and bone resorption areas of the present invention has a plurality of depressions of several μm to 500 μm on the surface, so it can be securely fixed at the desired filling location. Moreover, it is possible to promote the attachment and proliferation of new bone cells at an early stage. Furthermore, in addition to the above-mentioned surface structure, the internal structure of the filling material is dense, so it has sufficient strength and can be used in bone defects and bones in periodontal surgery, orthopedics, etc., which are susceptible to external forces. It is extremely useful as a filling material for cavities and bone resorption areas.

<実施例> 以下本発明を実施例及び比較例により詳細に説
明するが、本発明はこれらに限定されるものでは
ない。
<Examples> The present invention will be explained in detail below using Examples and Comparative Examples, but the present invention is not limited thereto.

実施例1、比較例1、2 湿式法で合成したヒドロキシアパタイト(以下
HApと称す)を焼成温度800℃で2時間仮焼した
のち、ボールミルを用いて平均粒径90μm以下に
粉砕し、HAp微細粒子を得た。得られたHAp微
細粒子を水と混合し、HApの固形物濃度が70重
量%のHApスラリー(以下HApスラリーAと称
す)を調製した。このスラリー化の際に、実施例
1ではスラリー100重量部に対し2重量部ポリカ
ルボン酸アンモニウム塩を添加し、気泡をよく巻
き込むために、十数分間よく撹拌混合した。次い
で得られたHApスラリーを80℃で乾燥した後、
焼成温度1200℃にて1時間焼成し粉砕して、粒子
の全表面に複数の窪みを形成し、次に最短径が
0.5〜1.0mmの粒子を篩分けした。最終にポツトミ
ルにてエツジ処理を行ない所望の充填材を得た
(実施例1)。得られた充填材表面に形成された窪
みの孔径を走査型電子顕微鏡により測定したとこ
ろ、数μm〜100μmの孔径を有しており、更に
深さは数μm〜50μmであつた。
Example 1, Comparative Examples 1 and 2 Hydroxyapatite synthesized by wet method (hereinafter referred to as
HAp) was calcined at a firing temperature of 800° C. for 2 hours, and then ground to an average particle size of 90 μm or less using a ball mill to obtain fine HAp particles. The obtained HAp fine particles were mixed with water to prepare an HAp slurry (hereinafter referred to as HAp slurry A) having a solid concentration of HAp of 70% by weight. In Example 1, 2 parts by weight of polycarboxylic acid ammonium salt was added to 100 parts by weight of the slurry, and the mixture was thoroughly stirred and mixed for more than 10 minutes to thoroughly incorporate air bubbles. Then, after drying the obtained HAp slurry at 80 °C,
The particles are fired for 1 hour at a temperature of 1200°C and then crushed to form multiple depressions on the entire surface of the particles, and then the shortest diameter is
Particles of 0.5-1.0 mm were sieved. Finally, edge treatment was performed in a pot mill to obtain a desired filler (Example 1). When the pore diameter of the depression formed on the surface of the obtained filler was measured using a scanning electron microscope, the pore diameter was several μm to 100 μm, and the depth was several μm to 50 μm.

得られた充填材粒子の拡大斜視図を第1図に示
し、充填材粒子の表面を更に拡大した平面図を1
a図及び1b図に示す。図において1は、実施例
1で得られた充填材粒子であつて、該粒状充填材
1の全表面には、孔径が小さい窪み11及び孔径
が大きい窪み12が、複数形成されている。粒子
充填材1の表面には、1a図及び1b図に示され
るとおり、小さい孔径11が密集する部分と、大
きい孔径12の周辺に小さい孔径11が密集する
部分とが存在していた。
An enlarged perspective view of the obtained filler particles is shown in Fig. 1, and a further enlarged plan view of the surface of the filler particles is shown in Fig. 1.
Shown in Figures a and 1b. In the figure, reference numeral 1 denotes the filler particles obtained in Example 1, and a plurality of depressions 11 with small pore diameters and depressions 12 with large pore diameters are formed on the entire surface of the granular filler 1. As shown in Figures 1a and 1b, on the surface of the particle filler 1, there were areas where small pores 11 were concentrated and areas where small pores 11 were concentrated around large pores 12.

また前記HApスラリーAを網目構造のウレタ
ン樹脂に含浸して80℃で乾燥した後、焼成温度
1200℃にて1時間焼成し粉砕した後、前記と同様
に篩分けを行ない、最短径が0.5〜1.0mmの多孔質
顆粒状の充填材を得た(比較例1)。
In addition, after impregnating the HAp slurry A into a network-structured urethane resin and drying it at 80°C, the firing temperature was
After baking at 1200° C. for 1 hour and pulverizing, the mixture was sieved in the same manner as described above to obtain a porous granular filler having a shortest diameter of 0.5 to 1.0 mm (Comparative Example 1).

更に、HApの乾燥物をインペラーブレーカー
にて粉砕した後、焼成温度1200℃にて1時間焼成
し、次いで前記と同様に篩分けし、ポツトミルに
てエツジ処理を行ない最短径が0.5〜1.0mmの緻密
質顆粒状の充填材を得た(比較例2)。
Furthermore, after pulverizing the dried HAp with an impeller breaker, it was fired at a firing temperature of 1200°C for 1 hour, then sieved in the same manner as above, and edge treated with a pot mill to produce powder with a shortest diameter of 0.5 to 1.0 mm. A dense granular filler was obtained (Comparative Example 2).

試験例 成犬の下顎骨に4mm×4mm×3mmの骨欠損部を
作製し、該骨欠損部に実施例1、比較例1、2で
得られた充填材を、それぞれ常法にしたがつて滅
菌処理した後圧入により充填した。術後1週間に
触診観察し、術後4週間に成犬を屠殺して標本を
作製し充填材部位の新生骨組織の形成状態につい
て観察した。実施例1で得られた充填材は、該骨
欠損部への充填操作が容易に行え、術後1週間の
触診時において既に該骨欠損部に確実に固定さ
れ、顎骨と同様の状態を示した。更に4週間後の
組織標本観察においては、骨に隣接した充填材顆
粒周辺部位に顕著に新生骨組織の形成が認めら
れ、しかも充填材を充填した部位の中心部まで骨
組織の形成が認められた。しかしながら比較例1
で得られた多孔質顆粒状充填材においては、該骨
欠損部に充填する際の圧入により充填材が砕けて
しまい、充填が困難であつた。またかろうじて充
填できた充填材も、術後1週間の触診の際や、通
常の咀嚼によつて充填材が破壊され、標本作製前
に該充填部位より吐出し、組織標本観察には至ら
なかつた。また比較例2で得られた緻密質充填材
においては、実施例1と同様に充填操作を容易に
行うことができ、術後4週間において、該骨欠損
部に充填材を固定することができたが、術後1週
間の触診時においては、充填材が確実に固定され
ていなかつたために、組織標本観察における新生
骨組織の形成状態の観察においては、充填材を充
填し部位の中心部にまで新生骨組織が形成されて
おらず、したがつて各々の充填材粒子は、早期に
新生骨と一体化させることはできなかつた。
Test Example A bone defect of 4 mm x 4 mm x 3 mm was created in the mandible of an adult dog, and the filling materials obtained in Example 1, Comparative Examples 1 and 2 were filled into the bone defect using the usual method. After sterilization, it was filled by press fitting. One week after the surgery, the dogs were observed by palpation, and four weeks after the surgery, the adult dogs were sacrificed to prepare specimens, and the state of formation of new bone tissue at the filling material site was observed. The filling material obtained in Example 1 could be easily filled into the bone defect, and when palpated one week after the surgery, it was already securely fixed to the bone defect and exhibited a condition similar to that of the jawbone. Ta. In addition, observation of the tissue specimen after 4 weeks showed that new bone tissue was noticeably formed in the area surrounding the filler granules adjacent to the bone, and bone tissue formation was also observed up to the center of the area filled with the filler. Ta. However, comparative example 1
In the porous granular filler obtained in the above, the filler broke during press-fitting when filling the bone defect, making it difficult to fill the bone defect. In addition, the filling material that could barely be filled was destroyed during palpation or normal chewing one week after the surgery, and was ejected from the filled site before specimen preparation, making it impossible to observe the tissue specimen. . Furthermore, with the dense filling material obtained in Comparative Example 2, the filling operation could be easily performed in the same manner as in Example 1, and the filling material could be fixed in the bone defect 4 weeks after the surgery. However, during palpation one week after surgery, the filling material was not securely fixed, so when observing the state of formation of new bone tissue during tissue specimen observation, it was difficult to place the filling material in the center of the site. No new bone tissue had been formed until then, and therefore each filler particle could not be integrated with the new bone at an early stage.

【図面の簡単な説明】[Brief explanation of drawings]

第1図は、実施例1により得られた骨欠損部及
び骨空〓部ならびに骨吸収部充填材の拡大斜視図
であり、図中第1a図は該充填材表面1部を更に
拡大した平面図、また図中第1b図は、同じく表
面の異なる部位を更に拡大した平面図である。 1……充填材本体、11……小さな孔径の窪
み、12……大きな孔径の窪み。
FIG. 1 is an enlarged perspective view of the bone defect, bone void, and bone resorption region filling material obtained in Example 1, and FIG. The figure, and FIG. 1b in the figure, are plan views in which different parts of the surface are further enlarged. 1... Filler main body, 11... Recess with small pore diameter, 12... Recess with large pore diameter.

Claims (1)

【特許請求の範囲】[Claims] 1 ヒドロキシアパタイトから成る粒子であつ
て、該粒子の最短径が0.1〜3.0mmであり、かつ表
面に孔径がμm〜500μmの複数の窪みを具備し
たことを特徴とする骨欠損部及び骨空〓部ならび
に骨吸収部充填材。
1. Bone defects and bone cavities, which are particles made of hydroxyapatite, the shortest diameter of which is 0.1 to 3.0 mm, and whose surface is provided with a plurality of depressions with pore diameters of μm to 500 μm. and bone resorption filler.
JP2146216A 1990-06-06 1990-06-06 Filler for bone omission part, bone cavity part, and bone absorption part Granted JPH0440961A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2146216A JPH0440961A (en) 1990-06-06 1990-06-06 Filler for bone omission part, bone cavity part, and bone absorption part

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2146216A JPH0440961A (en) 1990-06-06 1990-06-06 Filler for bone omission part, bone cavity part, and bone absorption part

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP6084577A Division JP2576404B2 (en) 1994-04-22 1994-04-22 Bone defect, bone void and bone resorbing part manufacturing method

Publications (2)

Publication Number Publication Date
JPH0440961A JPH0440961A (en) 1992-02-12
JPH0534021B2 true JPH0534021B2 (en) 1993-05-21

Family

ID=15402737

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2146216A Granted JPH0440961A (en) 1990-06-06 1990-06-06 Filler for bone omission part, bone cavity part, and bone absorption part

Country Status (1)

Country Link
JP (1) JPH0440961A (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995032008A1 (en) * 1994-05-24 1995-11-30 Implico B.V. A biomaterial and bone implant for bone repair and replacement
JP2003313146A (en) * 2002-04-19 2003-11-06 Showa Denko Kk Method for producing hydrofluorocarbon
JP5155058B2 (en) * 2008-08-05 2013-02-27 日本特殊陶業株式会社 Bone filler

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6120558A (en) * 1984-07-06 1986-01-29 柳沢 定勝 Bone lack part, bone cavity part and filler of bone absorbing part
JPS6179464A (en) * 1984-09-25 1986-04-23 ティーディーケイ株式会社 Composition for artificial bone material
JPS6179463A (en) * 1984-09-25 1986-04-23 ティーディーケイ株式会社 Composite apatite artificial bone material
JPS6179462A (en) * 1984-09-25 1986-04-23 ティーディーケイ株式会社 Porous artificial bone material
JPS63125258A (en) * 1986-11-14 1988-05-28 三菱マテリアル株式会社 Bone deficient part, gap part and absorbing part filler
JPS63125259A (en) * 1986-11-14 1988-05-28 旭光学工業株式会社 Calcium phosphate type porous bone filler
JPH062153B2 (en) * 1987-09-18 1994-01-12 三菱マテリアル株式会社 Filling material for bone defect and bone void
JPS63294864A (en) * 1987-10-23 1988-12-01 Tdk Corp Preparation of artificial bone material
JPH01158965A (en) * 1987-12-16 1989-06-22 Tokuyama Soda Co Ltd curable composition

Also Published As

Publication number Publication date
JPH0440961A (en) 1992-02-12

Similar Documents

Publication Publication Date Title
de Groot Ceramics of calcium phosphates: preparation and properties
US4629464A (en) Porous hydroxyapatite material for artificial bone substitute
US4963145A (en) Porous ceramic material and processes for preparing same
DE69729647T2 (en) Process for the preparation of calcium phosphate of low crystallinity and process for its use
FI64131C (en) FOERFARANDE FOER FRAMSTAELLNING AV POLYKRISTALLINT SINTRAT KERAMISKT MATERIAL
JPS6343106B2 (en)
CA2500722A1 (en) Inorganic shaped bodies and methods for their production and use
WO1995020368A1 (en) Cranio-maxillofacial bone defect repair
Boix et al. Injectable bone substitute to preserve alveolar ridge resorption after tooth extraction: a study in dog
JPH0359703B2 (en)
US8399009B2 (en) Bioceramic and biopolymer composite
JPH0254303B2 (en)
JPH0215221B2 (en)
JP2576404B2 (en) Bone defect, bone void and bone resorbing part manufacturing method
JP4802317B2 (en) Calcium phosphate ceramic bead assembly and method for constructing the same
JPH0534021B2 (en)
JPH0526504B2 (en)
Maté Sánchez de Val et al. Retracted: In vivo behavior of hydroxyapatite/β‐TCP/collagen scaffold in animal model. Histological, histomorphometrical, radiological, and SEM analysis at 15, 30, and 60 days
JPH0411215B2 (en)
JPS6120558A (en) Bone lack part, bone cavity part and filler of bone absorbing part
WO2003075973A1 (en) Spherical calcium phosphate molding and use thereof
JPS6179463A (en) Composite apatite artificial bone material
JPS62270164A (en) Substitute material for repairing living body hard tissue
JPS63294864A (en) Preparation of artificial bone material
JPH07115969B2 (en) Method for producing porous ceramic material